Magnesium sulfate infusion before very preterm delivery protects more babies from cerebral palsy
Cerebral palsy is the most common physical disability in childhood and is more likely to occur in babies born very preterm. The condition can affect movement, posture and coordination, with impacts that can last throughout life. New research led by SAHMRI has added to the growing evidence that giving a magnesium sulfate infusion to women at risk of very preterm birth helps more babies survive…
New research from SAHMRI reveals magnesium sulfate given to women at risk of very preterm birth helps more babies avoid cerebral palsy. The study, published in the American Journal of Obstetrics & Gynecology, found infants who received the treatment before delivery had a greater chance of surviving without the condition or moderate-to-severe functional impairment by 2–3 years old.
Dr. Emily Shepherd, the lead researcher, stated that the findings show magnesium sulfate is a life-changing treatment for families with very preterm babies, with benefits seen in real-world healthcare settings across Australia and New Zealand.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
